Details of the Drug Formulaction

General Information of Drug Formulation (ID: F09626)

• Formulation Name: Hydralazine 50 mg tablet
• Company: NCS HealthCare of KY, Inc dba Vangard Labs

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Hydralazine	(DMU8JGH)	Chronic heart failure	BD1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant